Results 141 to 150 of about 41,637 (195)

Development of IgY-Based Passive Immunization Against Tilapia Lake Virus: Development and In Vitro Neutralization Assays. [PDF]

Viruses
Setthawong P, Yamkasem J, Khemthong M, Tattiyapong P, Metheenukul P, Prasertsincharoen N, Lertwanakarn T, Thengchaisri N, Surachetpong W.   +8 more
europepmc   +1 more source

Insights from HIV-1 vaccine and passive immunization efficacy trials. [PDF]

Trends Mol Med
Ahmed S, Herschhorn A.
europepmc   +1 more source

The Road towards Polyclonal Anti-SARS-CoV-2 Immunoglobulins (Hyperimmune Serum) for Passive Immunization in COVID-19. [PDF]

Life (Basel), 2021
Focosi D, Tuccori M, Franchini M.
europepmc   +1 more source

Retraction: Passive Immunization Reduces Behavioral and Neuropathological Deficits in an Alpha-Synuclein Transgenic Model of Lewy Body Disease. [PDF]

PLoS One
PLOS ONE Editors.
europepmc   +1 more source

[Current Status of Passive Immunization Against COVID in Respiratory Patients]. [PDF]

Open Respir Arch
Mora Cuesta VM, Solís Gómez B, Pérez Rojo R.   +2 more
europepmc   +1 more source

Cooperation Between Systemic IgG1 and Mucosal Dimeric IgA2 Monoclonal Anti-HIV Env Antibodies: Passive Immunization Protects Indian Rhesus Macaques Against Mucosal SHIV Challenges. [PDF]

Front Immunol, 2021
Gong S, Lakhashe SK, Hariraju D, Scinto H, Lanzavecchia A, Cameroni E, Corti D, Ratcliffe SJ, Rogers KA, Xiao P, Fontenot J, Villinger F, Ruprecht RM.   +12 more
europepmc   +1 more source

Active and Passive Immunization of Syrian Hamsters with An Attenuated SARS-CoV-2 Protects against New Variants of Concern

, 2022
Wang T, Stauft C, Selvaraj P, D'agnillo F, Meseda C, Sangare K, Pedro C, Liu S, Lien C, Weir J, Starost M.   +10 more
europepmc   +1 more source

A novel HIV triple broadly neutralizing antibody (bNAb) combination-based passive immunization of infant rhesus macaques achieves durable protective plasma neutralization levels and mediates anti-viral effector functions. [PDF]

PLoS One
Dankwa S, Kosman C, Dennis M, Giorgi EE, Vuong K, Pahountis I, Garza A, Binuya C, McCarthy J, Mayer BT, Ngo JT, Enemuo CA, Carnathan DG, Stanfield-Oakley S, Berendam SJ, Weinbaum C, Engelman K, Magnani DM, Chan C, Ferrari G, Silvestri G, Amara RR, Chahroudi A, Permar SR, Fouda GG, Goswami R.   +25 more
europepmc   +1 more source

IgY - turning the page toward passive immunization in COVID-19 infection (Review). [PDF]

Exp Ther Med, 2020
Constantin C, Neagu M, Diana Supeanu T, Chiurciu V, A Spandidos D.   +4 more
europepmc   +1 more source

WHO preferred product characteristics for monoclonal antibodies for passive immunization against respiratory syncytial virus (RSV) disease in infants - Key considerations for global use.

Vaccine, 2022
Sparrow E, Adetifa I, Chaiyakunapruk N, Cherian T, Fell DB, Graham BS, Innis B, Kaslow DC, Karron RA, Nair H, Neuzil KM, Saha S, Smith PG, Srikantiah P, Were F, Zar HJ, Feikin D.   +16 more
europepmc   +1 more source